Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopausen AMS on Instagram

Features

  • How do we best support women in the workplace as they transition through menopause?
    By Dr Marita Long Women can experience a range of symptoms as they transition through the menopause years and some of these can have a significant impact on their attendance and performance in the workplace. This has given rise to considerable discussion and debate around how we can best support... Members Login to Read more...
  • eChanges December 2023
    Inside this issue  AMS News President's Report How do we best support women in the workplace as they transition through menopause? Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages Seasons Greetings IMS World Congress on Menopause in Melbourne 2024 News from Around the World... Members Login to Read more...
  • Neurodiverse Women and Menopause
    By Dr Carmel Reynolds There has been a relatively recent increase in community awareness of neurodivergence in women, and this has had a significant flow on effect in the numbers of women presenting for assessment. I am sure that most practitioners working in primary care and mental health fields... Members Login to Read more...
  • eChanges November 2023
    Inside this issue  AMS News President's Report Neurodiverse Women and Menopause Senate Inquiry into issues relating to menopause and perimenopause Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages IMS - A Special Membership Offer for Members of the Australasian Menopause Society IMS... Members Login to Read more...
  • A Practitioner’s Toolkit for the Management of the Menopause
    Developed by the Women’s Health Research Program in the Monash University School of Public Health and Preventive Medicine, 2023.The supporting notes for the Practitioner’s Toolkit for Managing Menopause are published, with free access, in Climacteric, the journal of the International Menopause... Read more...
  • Management of menopause
    By Dr Karen Magraith and Dr Christina Jang:  Menopausal hormone therapy is the most effective treatment for menopausal symptoms and, for most women, the benefits of symptom control outweigh the potential harms of therapy. The article is available free online from the Australian Prescriber, Issue 3... Read more...
  • IMS White Paper – Reproductive milestones across the lifespan and cardiovascular disease risk in women
    Cardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in... Read more...
  • eChanges September 2023
    Inside this issue  AMS News President's Report Updated AMS Information Sheet: Tibolone as menopausal hormone therapy 26th Annual Australasian Menopause Society Congress Synopsis New AMS Board Director: Dr Amie Hanlon AMS Congress Award and Prize Winners AMS Scholarship – Ms Celine Camon Menopause... Members Login to Read more...
  • Menopause Essentials Update 2023
    Saturday 4 November -  12.00-4.30pm  Join us for lunch followed by an update on the essentials of menopause management. This workshop is aimed at GPs, gynaecologists, endocrinologists and other health professionals who are seeking a comprehensive review of the current issues that face them in the... Read more...
  • FRAXplus®: Refining risk prediction
    Accurate assessment of fracture risk is essential for optimal diagnosis and management of osteoporosis.The FRAX® fracture risk assessment tool has substantially improved the identification of people at high risk of fracture since its launch in 2008. To date, 86 FRAX models have been made available... Members Login to Read more...
  • Primary Ovarian Insufficiency
    Loss of ovarian follicular activity (spontaneous or induced) before the age of 40 years constitutes primary ovarian insufficiency. It is characterized by hypergonadotropic hypogonadism (low estradiol and elevated gonadotropin levels) and results in loss of fertility and premature deficiency of... Members Login to Read more...
  • eChanges August 2023
    Inside this issue  AMS News President's Report Baseline (knowledge) and Basis (evidence) for Menopause Management New courses on AMS eLearning – Free for AMS members! Menopausal hormone therapy (MHT) patch shortages 26th AMS Congress, Queenstown, New Zealand, 1-3 September 2023 IMS World Congress on... Members Login to Read more...
  • Menopause in the Workplace after COVID Webinar
    Date:  7 September 2023 Time: 4.00 p.m. CET (Paris time) | 12.00 am AEST 8 September 2023  Speakers     The webinar will be recorded and you will be notified of the recording if you register to attend. Members Login to Read more...
  • Hormone Therapy use in the Aging Transgender Woman
    Sarah R Pickle, MD Associate Professor, Family and Community Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio  Dr Sarah Pickle discusses the risks and benefits of hormone therapy use in the aging transgender woman. There is no age cut-off for gender-affirming hormone use, and almost... Read more...
  • MENO-D
    By Dr Lina Safro The perimenopausal period encompasses a wide range of significant emotional symptoms. Listed in the AMS Score Sheet are the characteristic mood and cognitive changes including “brain fog”, irritability, “unloved feelings”, “anxiety” and “depression” (1). Studies indicate that... Members Login to Read more...
  • eChanges July 2023
    Inside this issue AMS News President's Report MENO-D Updated AMS Information Sheet: Osteoporosis Changes to AMS Guide to MHT/HRT Doses Call for Nominations - AMS Board Elections 2023-25 26th AMS Congress, Queenstown, New Zealand, 1-3 September 2023 AMS Scientific Publication Prize IMS World... Members Login to Read more...
  • Genetic causes of POI - 11 July 2023
    Moderator: Dr Wendy Wolfman Speakers: Prof Joop Laven: Advances in POI genetics Prof Randi Hagerman: Fragile X and POI Members Login to Read more...
  • Our Menopause World July 2023
    Webinar recording Pay Attention on Your Way In! The vulva is an important organ too The recording of the June webinar, held by Professor Rossella Nappi, Doctor Jan Shifren and Doctor Tami Rowen is now available online. Watch Free access to selected papers recently published in Climacteric The June issue of... Members Login to Read more...
  • eChanges June 2023
    Inside this issue  AMS News President's Report Selecting the progestogen for menopausal hormone therapy Updated AMS Information Sheet: AMS Guide to MHT/HRT Doses King’s Birthday Honours Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages 26th AMS Congress, Queenstown, New Zealand, 1-3... Members Login to Read more...
  • Our Menopause World June 2023
    President's Report General Update Dear Friends and Colleagues It gives me great pleasure to provide my latest president’s report for OMW in which I would particularly like to highlight the collaborative efforts of IMS to connect with our members and global partners. We are now approaching 1,000... Members Login to Read more...

Print Email

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopauseAMS on Instagram